Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...

Olumiant (baricitinib) is a prescribed treatment for severe alopecia areata in adults. It acts as an immunosuppressant by targeting enzymes that drive inflammation and contribute to hair follicle ...

A recent clinical trial found that combining the oral medication baricitinib with narrowband UV-B light therapy significantly improves outcomes for adults with severe and active nonsegmental vitiligo.

Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from baseline to week 36. In contrast, the placebo group saw a 9.2% change. The Janus ...

The camp will end with the exhibition match involving Filipinas players to be held at the newly-completed MOA Football Field, a rare opportunity for the Filipino fans to watch the team at home.

while preserving the heritage and cultural elements,” Loke said after witnessing the signing of a signing of a memorandum of agreement (MoA) on the project between Ipoh Sentral Sdn Bhd (ISSB ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- For adults with severe, active, nonsegmental vitiligo, baricitinib combined with narrowband ultraviolet light B (UV-B) is efficacious compared with placebo ...

Baricitinib, a Janus kinase (JAK) inhibitor, combined with narrowband ultraviolet B (UVB) phototherapy, reduced disease activity and improved repigmentation and quality of life in adults with ...

Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study.